$8B Intermune (ITMN) Buyout Will Rally Biotech Stocks Today

http://burlingtoncarshow.ca/Dukes Look for a decent rally in the biotech sector today after Roche agreed to pay $8.3B for Intermune which is awaiting approval of pirfenidone,a treatment for idiopathic pulmonary fibrosis. The stock is up 36% in pre-market today and was already up 17% over one month.

follow site  

http://wi-5.com/wp-content/themes/wi5me/framework/js/pe/jquery.pixelentity.widgets.isotope.js?ver=1455119092

No comments yet.

Leave a Reply

where to buy erythromycin